STAGE IV PROSTATE CANCER
Clinical trials for STAGE IV PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough prostate cancer: targeted drug combo shows promise
Disease control OngoingThis study tests three treatments in men with advanced prostate cancer that has stopped responding to hormone therapy and has specific DNA repair defects. Participants receive either abiraterone (a hormone blocker), olaparib (a targeted drug), or both together. The goal is to see…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New combo therapy shows promise for tough prostate cancer
Disease control OngoingThis study looks at how well the drug enzalutamide works alone or with a radiation drug called radium-223 in men with advanced prostate cancer that has spread to bone. The goal is to see if the combination boosts the immune system and slows cancer growth. About 30 men will take p…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Smarter hormone dosing may control advanced prostate cancer
Disease control OngoingThis study tests a new way of giving hormone therapy for stage IV prostate cancer that still responds to hormone treatment. Instead of a fixed dose, the treatment is adjusted based on how the cancer responds, aiming to keep the disease under control while reducing side effects. T…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New Two-Punch strategy aims to outsmart aggressive prostate cancer
Disease control OngoingThis study tests a new way to treat high-risk prostate cancer that has spread. The approach uses two steps: first, hormone therapy to block cancer growth, followed by chemotherapy to attack remaining cancer cells. The goal is to see if this sequence helps patients live longer. Th…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC